| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13678* | 2021 |
| Neuronal activity–induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis DK Ma, MH Jang, JU Guo, Y Kitabatake, M Chang, N Pow-Anpongkul, ... Science 323 (5917), 1074-1077, 2009 | 1014 | 2009 |
| Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice WX Ding, M Li, X Chen, HM Ni, CW Lin, W Gao, B Lu, DB Stolz, ... Gastroenterology 139 (5), 1740-1752, 2010 | 547 | 2010 |
| Early growth response gene 1–mediated apoptosis is essential for transforming growth factor β1–induced pulmonary fibrosis CG Lee, SJ Cho, MJ Kang, SP Chapoval, PJ Lee, PW Noble, ... The Journal of experimental medicine 200 (3), 377, 2004 | 479 | 2004 |
| TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression X Gao, Y Zhu, G Li, H Huang, G Zhang, F Wang, J Sun, Q Yang, X Zhang, ... PloS one 7 (2), e30676, 2012 | 434 | 2012 |
| CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery M Fransson, E Piras, J Burman, B Nilsson, M Essand, BF Lu, RA Harris, ... Journal of neuroinflammation 9, 1-12, 2012 | 343 | 2012 |
| Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death C Li, E Capan, Y Zhao, J Zhao, D Stolz, SC Watkins, S Jin, B Lu The Journal of Immunology 177 (8), 5163-5168, 2006 | 322 | 2006 |
| PD-1 blockade boosts radiofrequency ablation–elicited adaptive immune responses against tumor L Shi, L Chen, C Wu, Y Zhu, B Xu, X Zheng, M Sun, W Wen, X Dai, ... Clinical Cancer Research 22 (5), 1173-1184, 2016 | 263 | 2016 |
| Immune modulation by volatile anesthetics LM Stollings, LJ Jia, P Tang, H Dou, B Lu, Y Xu Anesthesiology 125 (2), 399-411, 2016 | 262 | 2016 |
| Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics ZS Guo, B Lu, Z Guo, E Giehl, M Feist, E Dai, W Liu, WJ Storkus, Y He, ... Journal for immunotherapy of cancer 7, 1-21, 2019 | 257 | 2019 |
| TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action W Du, M Yang, A Turner, C Xu, RL Ferris, J Huang, LP Kane, B Lu International journal of molecular sciences 18 (3), 645, 2017 | 251 | 2017 |
| Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells X Gao, X Wang, Q Yang, X Zhao, W Wen, G Li, J Lu, W Qin, Y Qi, F Xie, ... The Journal of Immunology 194 (1), 438-445, 2015 | 248 | 2015 |
| An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma Y Tang, X Xu, S Guo, C Zhang, Y Tang, Y Tian, B Ni, B Lu, H Wang PloS one 9 (3), e91551, 2014 | 244 | 2014 |
| Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery JR Kovacs, C Li, Q Yang, G Li, IG Garcia, S Ju, DG Roodman, JJ Windle, ... Cell Death & Differentiation 19 (1), 144-152, 2012 | 242 | 2012 |
| IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cells Q Yang, G Li, Y Zhu, L Liu, E Chen, H Turnquist, X Zhang, OJ Finn, ... European journal of immunology 41 (11), 3351-3360, 2011 | 230 | 2011 |
| Soluble CD276 (B7‐H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum G Zhang, J Hou, J Shi, G Yu, B Lu, X Zhang Immunology 123 (4), 538-546, 2008 | 220 | 2008 |
| GADD45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells B Lu, H Yu, C Chow, B Li, W Zheng, RJ Davis, RA Flavell Immunity 14 (5), 583-590, 2001 | 218 | 2001 |
| Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion RL Ferris, B Lu, LP Kane The Journal of Immunology 193 (4), 1525-1530, 2014 | 210 | 2014 |
| Cytokine-induced killer cells promote antitumor immunity J Jiang, C Wu, B Lu Journal of translational medicine 11, 1-9, 2013 | 210 | 2013 |
| T-bet and eomesodermin are required for T cell-mediated antitumor immune responses Y Zhu, S Ju, E Chen, S Dai, C Li, P Morel, L Liu, X Zhang, B Lu The Journal of Immunology 185 (6), 3174-3183, 2010 | 207 | 2010 |
Richard A. FlavellSterling Professor of Immunobiology, Yale University, HHMI Investigator在 yale.edu 的电子邮件经过验证
